Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription ... Mandibular Advancement Devices are the most commonly used mouthguards for sleep apnea. These help keep the ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep, they stop ...

INSIDE INFORMATIONREGULATED INFORMATIONFDA Issues Nyxoah an Approvable Letter for its Genio® SystemMont-Saint-Guibert, Belgium – March 26, 2025, ...

Doctors might also consider custom-made oral devices to correctly position ... In 2024, the Food and Drug Administration (FDA) approved the first sleep apnea medication, Zepbound, for use by ...

Another wearable device for sleep apnea delivers bilevel positive airway pressure (BPAP). More recently, the Food and Drug Administration (FDA) approved an implantable upper airway stimulation ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Opens in a new tab or window The FDA recently approved the first drug specifically for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity: tirzepatide (Zepbound).

When you or your bed partner has sleep apnea, a restful night’s sleep can be hard to come by. Treating this common condition ...

Compumedics has received FDA approval to market Falcon ... for Falcon HST further underpins its US sleep business growth strategy, with the device set to complement its proprietary Somfit ...

Nearly 9 in 10 adults (88%) recognized CPAP therapy, but more than 40% weren't aware of options like surgery, implantable devices ... FDA-approved treatment for those with obstructive sleep apnea ...

It’s already FDA-approved to manage diabetes and obesity — now, researchers at UC San Diego have gotten it approved as the first effective drug therapy for sleep apnea. “Systolic blood ...